TY - JOUR
T1 - A systems biology approach towards the identification of candidate therapeutic genes and potential biomarkers for Parkinson’s disease
AU - Sakharkar, Meena Kishore
AU - Singh, Sarinder Kaur Kashmir
AU - Rajamanickam, Karthic
AU - Essa, Musthafa Mohamed
AU - Yang, Jian
AU - Chidambaram, Saravana Babu
N1 - Publisher Copyright:
© 2019 Sakharkar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Parkinson’s disease (PD) is an irreversible and incurable multigenic neurodegenerative disorder. It involves progressive loss of mid brain dopaminergic neurons in the substantia nigra pars compacta (SN). We compared brain gene expression profiles with those from the peripheral blood cells of a separate sample of PD patients to identify disease-associated genes. Here, we demonstrate the use of gene expression profiling of brain and blood for detecting valid targets and identifying early PD biomarkers. Implementing this systematic approach, we discovered putative PD risk genes in brain, delineated biological processes and molecular functions that may be particularly disrupted in PD and also identified several putative PD biomarkers in blood. 20 of the differentially expressed genes in SN were also found to be differentially expressed in the blood. Further application of this methodology to other brain regions and neurological disorders should facilitate the discovery of highly reliable and reproducible candidate risk genes and biomarkers for PD. The identification of valid peripheral biomarkers for PD may ultimately facilitate early identification, intervention, and prevention efforts as well.
AB - Parkinson’s disease (PD) is an irreversible and incurable multigenic neurodegenerative disorder. It involves progressive loss of mid brain dopaminergic neurons in the substantia nigra pars compacta (SN). We compared brain gene expression profiles with those from the peripheral blood cells of a separate sample of PD patients to identify disease-associated genes. Here, we demonstrate the use of gene expression profiling of brain and blood for detecting valid targets and identifying early PD biomarkers. Implementing this systematic approach, we discovered putative PD risk genes in brain, delineated biological processes and molecular functions that may be particularly disrupted in PD and also identified several putative PD biomarkers in blood. 20 of the differentially expressed genes in SN were also found to be differentially expressed in the blood. Further application of this methodology to other brain regions and neurological disorders should facilitate the discovery of highly reliable and reproducible candidate risk genes and biomarkers for PD. The identification of valid peripheral biomarkers for PD may ultimately facilitate early identification, intervention, and prevention efforts as well.
UR - http://www.scopus.com/inward/record.url?scp=85071743995&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071743995&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0220995
DO - 10.1371/journal.pone.0220995
M3 - Article
C2 - 31487305
AN - SCOPUS:85071743995
SN - 1932-6203
VL - 14
JO - PLoS One
JF - PLoS One
IS - 9
M1 - e0220995
ER -